AI assistant
Neuland Laboratories Limited. — Call Transcript 2019
Aug 8, 2019
62255_rns_2019-08-08_c11cfa8d-63e3-4697-8ba0-5a3ba97611e5.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [120 x 41] intentionally omitted <==
==> picture [112 x 5] intentionally omitted <==
==> picture [480 x 8] intentionally omitted <==
==> picture [81 x 48] intentionally omitted <==
Neuland Laboratories Limited’s Q1 FY 2019-20 Results Conference Call
At 11:00 hrs. IST on August 14, 2019
Neuland Laboratories Limited will announce its results for the first quarter ended June 30, 2019 on August 13, 2019. The results will also be made available on the website of the Company, www.neulandlabs.com.
Following the announcement, the management of the Company will host an Earnings Call on the 14 August at 11:00 hrs . The details of the earnings call are:
Date: August 14, 2019
Time: 11:00 Hrs.
Dial-in Number: +91 22 6280 1107 / +91 22 7115 8008
Other Numbers:
Local Access Number
+91 70456 71221 (Available all over India)
International Toll-Free Number
USA – 18667462133 | UK – 08081011573 | Singapore – 8001012045 | Hong Kong – 800964448
About Neuland Laboratories Limited (BSE:524558, NSE: NEULANDLAB)
For over 35 years, Neuland Labs has been at the forefront of manufacturing APIs through its cGMP manufacturing facilities, working with customers in close to 80 countries. Neuland Labs has developed more than 300 processes and 75 APIs, and it has filed around 57 U.S. drug master files (USDMFs) and over 673 Regulatory filings in the European Union (EU) and other geographies. Its manufacturing facilities are inspected and approved by the U.S. FDA and other leading regulatory agencies. Its record of quality manufacturing and reliability is highlighted by cGMP certifications that include the U.S. FDA, TGA (Australia), EDQM (EU), German Health Authority, ANVISA (Brazil), EMA (EU), Cofepris (Mexico), KFDA (Korea), PMDA (Japan), CFDA (China), FSI “SID &GP” Russia, Health Canada, ISO 9001, ISO14001, OHSAS18001 and ISO 27001.
For more information, visit www.NeulandLabs.com.
For Queries:
Neuland : [email protected] or Diwakar Pingle: [email protected]